# Scapa Healthcare to acquire Systagenix wound dressing facility in UK

Scapa Healthcare has signed an agreement to purchase the Systagenix manufacturing facility in Gargrave, England from Acelity. The 335,000-square-foot site will be transferred to Scapa Healthcare along with a long-term manufacturing and supply agreement for advanced wound dressings.

- Type: Acquisition
- Announced: 2018-09-13
- Where: Gargrave, England, United Kingdom
- Status: announced
- Products: advanced wound dressings
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Scapa Healthcare](https://endata.com/companies/30884.md) (acquirer)
- [Acelity](https://endata.com/companies/32477.md) (partner)

## Sources

- [scapahealthcare.com](https://www.scapahealthcare.com/news/healthcare-news-details/2018/09/13/scapa-healthcare-enters-agreement-to-acquire-advanced-wound-dressing-facility-in-the-uk), 2018-09-13: "This technology transfer is in line with our growth strategy, and we are excited about the opportunities this facility brings as we continue to expand our portfolio of turn-key solutions."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.